I think that the number that was published by CCPA and peer-reviewed is a credible estimate. I would like to see, as I said, the internal official estimates and, again, I think you should ask for them.
I'll just point out that a lot of the savings that you've referred to, over the last 10 years, depended upon the availability of cheaper generic substitutes for more expensive brand-name drugs, and that will be impaired by the changes in CETA.